CrossRef The role of the resveratrol-sirtuin axis in the treatment of metabolic dysfunction-associated diseases Jiale Yang, Shuping Chen, Tiantian Zeng, Yuxuan Zhang, Zhaoxin Li, Haifang Li Exploration of Endocrine and Metabolic Diseases .2026;[Epub] CrossRef GLP-1 receptor agonistSGLT-2 inhibitor combination and risk of major adverse liver and cardiovascular outcomes in adults with MASLD and type 2 diabetes Xianhua Mao, Hong Fan, Man-Fung Yuen, Ramsey Cheung, Wai-Kay Seto, Mindie H
For patients who cannot tolerate semaglutide, a range of alternative pharmacological treatments and lifestyle interventions are available
doi:10.1038/s41598-021-92753-4
While the combination of Ozempic and HCG is a topic of conversation in some weight loss circles, the lack of clinical evidence and the risks associated with extreme caloric restriction make it a questionable choice for most
He completed his Ph.D